...
首页> 外文期刊>Journal of Molecular and Cellular Cardiology >Combined angiotensin and endothelin receptor blockade attenuates adverse cardiac remodeling post-myocardial infarction in the rat: possible role of transforming growth factor beta(1).
【24h】

Combined angiotensin and endothelin receptor blockade attenuates adverse cardiac remodeling post-myocardial infarction in the rat: possible role of transforming growth factor beta(1).

机译:联合血管紧张素和内皮素受体阻滞剂减轻大鼠心肌梗死后不良的心脏重塑:转化生长因子β(1)的可能作用。

获取原文
获取原文并翻译 | 示例

摘要

A. Tzanidis, S. Lim, R. D. Hannan, F. See, A. M. Ugoni and H. Krum. Combined Angiotensin and Endothelin Receptor Blockade Attenuates Adverse Cardiac Remodeling Post-Myocardial Infarction in the Rat: Possible Role of Transforming Growth Factor beta(1). Journal of Molecular and Cellular Cardiology (2001) 33, 969-981. Myocardial infarction (MI) is associated with activation of the vasoconstrictor peptides, angiotensin II (AngII) and endothelin-1 (ET-1), which are thought to contribute to adverse cardiac remodeling and dysfunction. The present study sought to determine whether combined AngII and ET receptor blockade improves cardiac remodeling over individual treatments in an experimental model of left ventricular myocardial infarction (LVMI) in the rat. Groups of eight female Sprague-Dawley rats were randomized at 24 h post-LVMI to 1 week treatment with either vehicle, an ET(A/B)receptor antagonist (bosentan), an AT(1)receptor antagonist (valsartan), or combined treatment. Vehicle-treated animals developed LV dysfunction with extensive accumulation of collagen type I and increased alpha(1)(I) procollagen mRNA compared to sham controls. Whilst individual receptor blockade with either bosentan or valsartan reduced LVEDP towards sham control levels, there were no significant changes to myocardial collagen deposition in comparison to vehicle. In contrast, improved ventricular function by combined treatment was associated with reduced type I collagen deposition within left ventricular non-infarct regions, as well as reduced peptide distribution and cardiac gene expression of the profibrogenic peptide, transforming growth factor beta(1)(TGF beta(1)). These data demonstrate that combined AngII and ET receptor blockade has beneficial effects on myocardial fibrogenesis over individual treatments during adverse cardiac remodeling early post-MI. Copyright 2001 Academic Press.
机译:A. Tzanidis,S。Lim,R。D. Hannan,F。见A. M. Ugoni和H. Krum。组合的血管紧张素和内皮素受体阻滞剂减轻大鼠心肌梗死后的不良心脏重塑:转化生长因子β(1)的可能作用。 Journal of Molecular and Cellular Cardiology(2001)33,969-981。心肌梗塞(MI)与血管收缩肽,血管紧张素II(AngII)和内皮素1(ET-1)的激活有关,这些物质可导致不良的心脏重塑和功能障碍。本研究试图确定在大鼠左心室心肌梗死(LVMI)实验模型中,AngII和ET受体联用阻滞是否比单独的治疗改善了心脏重塑。八只Sprague-Dawley雌性大鼠组在LVMI后24小时随机分为1种媒介物,一种ET(A / B)受体拮抗剂(波生坦),一种AT(1)受体拮抗剂(缬沙坦)或联合治疗治疗。与假手术对照组相比,用车辆治疗的动物发展出LV功能障碍,并大量积累I型胶原蛋白并增加了alpha(1)(I)前胶原mRNA。尽管波生坦或缬沙坦的单个受体阻滞剂可将LVEDP降低至假对照水平,但与溶媒相比,心肌胶原沉积没有显着变化。相反,通过联合治疗改善心室功能与减少左心室非梗死区域中的I型胶原沉积,减少原纤维形成肽的肽分布和心脏基因表达,转化生长因子β(1)(TGFβ (1))。这些数据表明,在心梗后早期不良心脏重塑期间,联合使用AngII和ET受体阻滞剂对心肌纤维生成具有优于单个治疗的有益作用。版权所有2001学术出版社。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号